Barclays’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-90,000
Closed -$3.93M – 5323
2025
Q1
$3.93M Buy
+90,000
New +$3.92M ﹤0.01% 2100

Other funds holding DBD

Barclays's DBD Position: Q3 2026 in Review

Barclays increased its Diebold Nixdorf (DBD) stake by 69% in Q3 2026, buying an estimated $371K and bringing the position to 12,408 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #3228.

Barclays first reported a position in DBD in Q4 2023 and has held it in 12 quarters since. The position peaked at $8.34M in Q2 2024. 215 funds tracked by Wall St. Rank hold DBD as of Q3 2026.

  • Barclays held 12,408 shares of Diebold Nixdorf worth $760K as of Q3 2026.
  • Barclays bought 5,058 Diebold Nixdorf shares in Q3 2026, an estimated $371K.
  • Diebold Nixdorf made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3228 holding.
  • Barclays first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 12 quarters since.
  • Barclays's Diebold Nixdorf position peaked at $8.34M in Q2 2024.
  • 215 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.